Serendipity: decitabine monotherapy induced complete molecular response in a 77-year-old patient with acute promyelocytic leukemia

Haematologica. 2019 Apr;104(4):e170-e173. doi: 10.3324/haematol.2018.209478. Epub 2019 Feb 7.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, N.I.H., Extramural

MeSH terms

  • Aged
  • Antigens, CD / blood
  • Decitabine / administration & dosage*
  • Female
  • Humans
  • Leukemia, Promyelocytic, Acute / blood
  • Leukemia, Promyelocytic, Acute / drug therapy*
  • Leukemia, Promyelocytic, Acute / pathology
  • Oncogene Proteins, Fusion / blood

Substances

  • Antigens, CD
  • Oncogene Proteins, Fusion
  • promyelocytic leukemia-retinoic acid receptor alpha fusion oncoprotein
  • Decitabine